Odimma Therapeutics
Overview
Odimma Therapeutics is a biotech company headquartered in France, focused on the development of innovative immunotherapies for treating various forms of cancer. The company is dedicated to advancing personalized therapeutic solutions using cutting-edge technologies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Odimma Therapeutics in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.